Targeting Glycoprotein NMB With Antibody‐Drug Conjugate, Glembatumumab Vedotin, for the Treatment of OsteosarcomaMichael Roth, Richard Görlick, David S. Geller et al.|Pediatric Blood & Cancer|2015Cited by 58